Last week Oxysure Systems Inc (OTCMKTS:OXYS) reported that it retained Donohoe Advisory Associates LLC to advise and help the company in its initiatives to obtain a listing on a reputed national securities exchange. The advisory firm, established by David A Donohoe, Jr., has successfully represented several firms seeking to list on national stock exchanges. Bruce Poignant, Senior Consultant of advisory firm will also be working on the project.
Julian Ross, the CEO said that he has known Mr. Poignant since a long time and the entire team is delighted to be working with Donohoe Advisory. Oxysure Systems look forward to the expert counsel and advice on seeking a listing on national exchange.
Oxysure Systems Inc (OTCMKTS:OXYS) revenue in 2Q2015 jumped 54% to $1.046 million compared to $678,111 for the previous period. The revenue in 1H2015 increased 62% to $1.670 million compared to $1.034 million in 1H2014. With this, the company successfully reported eleventh consecutive quarter of robust sales growth.
On a consecutive quarter basis Oxysure managed to delight the investors. The revenue shot 67% from 1Q2015 to 2Q2015.The net loss narrowed to $0.04 per share in 2Q2015 compared to $0.05 per share in 1Q2015. Sequentially, the gross profit was up 120% while it surged 54% YOY to $636,836 compared to $413,255.
The stocks in focus
Alphatec Holdings Inc (NASDAQ:ATEC), a reputed company operational in the same sector, reported 2Q2015 results earlier in the month. The company’s consolidated net revenue came at $46.6 million and adjusted EBITDA stood at $3.8 million. Alphatec management reported that operational transformation measures are underway as they work to enhance underlying cost structure in coming years.
The other firm that is in focus is Zimmer Biomet Holdings Inc (NYSE:ZBH). After the closure of a $14 billion mega merger between Biomet and Zimmer holdings, the new combined entity, posted better than expected 2Q2015 results. The company considers the merger as a strategic fit which will prove advantageous for providers, stakeholders and patients in the healthcare industry.